How many types of cancer does obesity actually cause?
For years, the medical community recognized 13 cancers as 'obesity-related,' including postmenopausal breast, colorectal, endometrial, kidney, pancreatic, and liver cancers [2][3]. But a massive 2024 study of 4.1 million Swedish adults—the largest of its kind here—shattered that list. It identified 15 additional cancers in men and 16 in women that are likely linked to obesity, including cancers of the head and neck, stomach, small intestine, cervix, thyroid, and even malignant melanoma and some blood cancers [1]. The risk increase for these 'new' cancers was comparable to the already-established ones: for every 5-unit increase in BMI, risk rose by about 13-17% [1]. This means the true cancer burden from obesity is much larger than previously thought.
The same study also revealed that obesity doesn't just raise risk uniformly—it can affect subtypes of the same cancer differently. For example, the link was stronger for certain types of stomach cancer, small intestine cancer, and cervical cancer than for others [1]. This nuance helps explain why some earlier, smaller studies might have missed the connection.
Does losing weight actually lower your cancer risk?
Yes, and the evidence is powerful. A landmark 2022 study from the SPLENDID trial followed over 30,000 adults with severe obesity (average BMI of 45) for about 6 years. Those who had bariatric surgery lost an average of 19% more of their body weight than those who didn't have surgery [2]. The results were striking: the surgery group had a 32% lower risk of developing an obesity-related cancer (2.9% vs. 4.9% at 10 years) and a 48% lower risk of dying from cancer (0.8% vs. 1.4% at 10 years) [2][3]. These are not small effects—they translate to roughly 2 fewer cancer cases and 0.6 fewer cancer deaths per 100 people over a decade.
This finding is consistent across multiple large observational studies. A pooled analysis of 8 such studies, involving over 600,000 patients, found that bariatric surgery was associated with a 28% lower risk of all cancers and a 45% lower risk of obesity-related cancers specifically [3]. While these are observational studies (not randomized trials), the consistency and size of the effect strongly suggest that intentional, sustained weight loss is one of the most powerful cancer prevention strategies available.
Is it just about weight, or does metabolic health matter too?
It's both—and the combination is especially dangerous. A 2023 pooled study of nearly 800,000 Europeans found that people with 'metabolically unhealthy obesity' (obesity plus high blood pressure, high blood sugar, or high triglycerides) had the highest risk for several cancers, including endometrial, liver, and kidney cancer (2.5 to 3 times higher risk compared to healthy-weight people with good metabolic health) [4]. But even 'metabolically healthy obesity' (obesity without those metabolic problems) still carried a significantly higher risk for colon, endometrial, kidney, liver, and gallbladder cancers [4]. The key takeaway: obesity itself drives cancer risk, but metabolic problems add fuel to the fire.
This helps explain why some people with a normal weight can still be at risk. The concept of 'metabolically obese, normal weight' (MONW) individuals—people with a normal BMI but high visceral fat and metabolic issues—is increasingly recognized, especially in Asian populations [5]. So, while BMI is a useful starting point, waist circumference and metabolic markers (blood pressure, glucose, lipids) give a more complete picture of cancer risk.
About These Sources
This answer is built on 5 peer-reviewed studies — published from 2022 to 2024, 1 from 2024 or later, 5 in Q1 journals, collectively cited 412 times — selected as the most relevant from 9 studies that passed quality screening, drawn from 65 papers retrieved from a database of over 500 million.
Sources used in this answer
Body mass index and risk of over 100 cancer forms and subtypes in 4.1 million individuals in Sweden: the Obesity and Disease Development Sweden (ODDS) pooled cohort study
In a pooled cohort of 4.1 million Swedish adults, obesity (BMI ≥30) was linked to 15 potential new obesity-related cancers in men and 16 in women (beyond the established 13), with risk increases per 5-unit BMI rise of 17% in men and 13% in women for these new cancers [1].
Association of Bariatric Surgery With Cancer Risk and Mortality in Adults With Obesity
In a matched cohort study of 30,318 adults with severe obesity, bariatric surgery was associated with a 32% lower risk of developing an obesity-associated cancer and a 48% lower risk of cancer-related death over 10 years [2].
Bariatric Surgery and Cancer Risk
This editorial summarizing multiple observational studies (including over 600,000 patients) reports that bariatric surgery is consistently associated with a reduced risk of all cancers (pooled odds ratio 0.72) and obesity-associated cancers (pooled odds ratio 0.55) [3].
Metabolically (un)healthy obesity and risk of obesity-related cancers: a pooled study
In a pooled study of 797,193 Europeans, metabolically unhealthy obesity was associated with the highest risk for several cancers (e.g., HR 2.55-3.00 for endometrial, liver, and kidney cancer), but even metabolically healthy obesity carried elevated risks for colon, endometrial, and kidney cancers [8].
Obesity, obesities and gastrointestinal cancers
This review highlights that obesity is heterogeneous—visceral obesity and metabolic syndrome are key drivers of gastrointestinal cancers (esophageal, liver, pancreatic, colorectal), and that BMI alone may miss risk in some populations (e.g., metabolically obese normal-weight individuals) [9].